Sana Biotechnology, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sana Biotechnology, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Sana Biotechnology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $61M, a 21% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $61M -$16.2M -21% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $63.2M -$31.6M -33.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $71.6M -$26.6M -27.1% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $74.9M -$17.6M -19% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $77.2M -$18.5M -19.3% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $94.7M -$4.2M -4.24% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $98.1M +$971K +1% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $92.5M -$3.83M -3.98% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $95.7M +$10.9M +12.9% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $98.9M +$38.6M +63.9% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $97.1M +$35.4M +57.3% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $96.3M +$33.2M +52.5% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $84.8M Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $60.3M Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $61.8M Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $63.2M Dec 31, 2020 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.